Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.99
-0.44 (-1.36%)
At close: Aug 10, 2026, 4:00 PM EDT
31.99
0.00 (0.00%)
After-hours: Aug 10, 2026, 4:20 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $2.02 billion as of August 10, 2026. Its market cap has increased by 229.99% in one year.
Market Cap
2.02B
Enterprise Value
1.57B
1-Year Change
229.99%
Ranking
Category
Stock Price
$31.99
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $2.02B, an increase of 198.56%. That is a compound annual growth rate of 77.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.02B | 3.62% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 2.18B |
| AbCellera Biologics | 2.12B |
| Stoke Therapeutics | 2.11B |
| Aurinia Pharmaceuticals | 2.11B |
| Taysha Gene Therapies | 2.10B |
| GH Research | 2.08B |
| Mesoblast | 2.05B |
| Ocular Therapeutix | 2.02B |